Searching for Standing: Benefit-of-the-Bargain Theory of Injury
Federal circuit courts are split on whether consumers who purchase defective products suffer an Article III injury in fact at the point of sale, even when the defect never manifests in their particular product. Courts recognizing the benefit-of-the-bargain theory treat overpayment as a concrete economic harm sufficient to confer standing: Consumers paid more than a product was worth because of a latent defect, and that shortfall in value is the injury. Courts requiring defect manifestation reject this theory as speculative, insisting that a product must malfunction or cause physical harm before any cognizable injury exists. The divide carries high stakes at the intersection of Article III standing and Federal Rule of Civil Procedure 23, where the availability of the benefit-of-the-bargain theory can determine whether a class is certifiable and, in turn, whether consumers retain any meaningful path to aggregate relief. This Comment argues that courts dismissing the benefit-of-the-bargain theory as a novel plaintiffs’ invention are wrong. It advances two independent historical arguments demonstrating that overpayment injury is firmly rooted in legal tradition. First, drawing on the English bill of peace—the equitable predecessor to the modern class action—it shows that equity courts entertained representative suits for shared economic harms without requiring uniform defect manifestation or identical individual losses. Second, it identifies common law analogues in breach of contract and warranty doctrine, in which the buyer’s injury has always been complete at the moment of acceptance, when goods worth less than promised are delivered. These historical foundations satisfy the Supreme Court’s “history and tradition” framework articulated in Spokeo, Inc. v. Robins and TransUnion LLC v. Ramirez, and they demonstrate that manifest defect requirements impose a second injury threshold that Article III does not demand.